The FDA approved a proximal hypoglossal nerve stimulation device (aura6000 system) for adults with moderate to severe obstructive sleep apnea (OSA), maker LivaNova announced on Thursday. FDA's ...

Immunomodulatory approaches such as GRI-0621 (RARβγ agonist targeting iNKT activity) may support alveolar basement membrane repair and provide complementary biology for oral combination regimens.

53 percent) of the 30,000 people surveyed across 13 countries in December 2025 and January 2026 ranked sleep as the most important behavior for living a long, healthy life, ahead of eating a balanced ...

Individuals with chronic obstructive pulmonary disease (COPD) with coexisting obstructive sleep apnea (OSAS) have greater ...

Chronic obstructive pulmonary disease (COPD) is known for causing breathing difficulties and limiting everyday activities.

Chronic obstructive pulmonary disease, commonly called COPD, is a long-term lung condition that makes breathing difficult. It usually develops after many years of exposure to harmful particles, ...

This chart shows the most common factors regarded as contributing to a poor night's sleep in 2026 (in percent).

Cannabis products containing delta-8 THC have spiked in popularity in recent years, from gummies and brownies to vapes, pre-rolls, and tinctures. These products are frequently marketed as "legal" ...

ResMed is one of the largest companies in the business of respiratory care devices. More specifically, it makes equipment ...

A nerve stimulator implant called Inspire is helping some sleep apnea patients breathe normally at night when a CPAP machine is not an effective treatment.

ResMed Inc. advanced stock charts by Barron's. View RMD historical stock data and compare to other stocks, and exchanges.

Sleep apnea sufferers may soon have a new path to a good night’s sleep. A Massachusetts biotech startup is preparing to file for FDA approval of a once-nightly pill that could become the first ...